CABERGOLINE APOTEX cabergoline 500 micrograms tablets bottle Australia - engelsk - Department of Health (Therapeutic Goods Administration)

cabergoline apotex cabergoline 500 micrograms tablets bottle

arrotex pharmaceuticals pty ltd - cabergoline, quantity: 500 microgram - tablet - excipient ingredients: lactose; magnesium stearate - ? inhibition of physiological lactation ,cabergoline is indicated for the prevention of the onset of physiological lactation in the puerperium for clearly defined medical reasons. ,? treatment of hyperprolactinaemic disorders ,cabergoline is indicated for the treatment of pathological hyperprolactinaemia.

Dostinex New Zealand - engelsk - Medsafe (Medicines Safety Authority)

dostinex

pfizer new zealand limited - cabergoline 0.5mg - tablet - 0.5 mg - active: cabergoline 0.5mg excipient: lactose leucine - prevention of the onset of lactation in the puerperium only for clearly defined medical reasons: dostinex is indicated for the inhibition of physiological lactation soon after delivery. 1. after parturition, when breast feeding is contraindicated due to medical reasons related to the mother or the new-born. 2.after stillbirth or abortion.

Cabergoline 1 mg Tablets Irland - engelsk - HPRA (Health Products Regulatory Authority)

cabergoline 1 mg tablets

renata pharmaceuticals (ireland) limited - cabergoline - tablet - cabergoline

Cabergoline 2 mg Tablets Irland - engelsk - HPRA (Health Products Regulatory Authority)

cabergoline 2 mg tablets

renata pharmaceuticals (ireland) limited - cabergoline - tablet - cabergoline

Cabergoline Sandoz tablet 0,5 mg, tabletten Nederland - nederlandsk - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

cabergoline sandoz tablet 0,5 mg, tabletten

sandoz b.v. - cabergoline - tablet - lactose 0-water ; leucine, (l-), - cabergoline

TINEXA cabergoline 0.5mg tablets bottle Australia - engelsk - Department of Health (Therapeutic Goods Administration)

tinexa cabergoline 0.5mg tablets bottle

arrotex pharmaceuticals pty ltd - cabergoline, quantity: 0.5 mg - tablet, uncoated - excipient ingredients: leucine; lactose monohydrate - inhibition of physiological lactation. prevention of the onset of physiological lactation in the puerperium for clearly defined medical reasons. treatment of hyperprolactinaemic disorders. treatment of pathological hyperprolactinaemia.

ACT CABERGOLINE Comprimé Canada - fransk - Health Canada

act cabergoline comprimé

teva canada limited - cabergoline - comprimé - 0.5mg - cabergoline 0.5mg - ergot-derivative dopamine receptor agonists

ACT CABERGOLINE TABLET Canada - engelsk - Health Canada

act cabergoline tablet

teva canada limited - cabergoline - tablet - 0.5mg - cabergoline 0.5mg - ergot-derivative dopamine receptor agonists

CABERGOLINE 0.5 MILLIGRAM TABLETS 0.5 Milligram Tablets Irland - engelsk - HPRA (Health Products Regulatory Authority)

cabergoline 0.5 milligram tablets 0.5 milligram tablets

arrow generics limited - cabergoline - tablets - 0.5 milligram

CABERGOLINE Teva 1 mg, comprimé sécable Frankrike - fransk - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

cabergoline teva 1 mg, comprimé sécable

teva classics - cabergoline - comprimé - 1,0 mg - composition pour un comprimé > cabergoline : 1,0 mg - groupe agoniste dopaminergique -